Compare PSFE & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSFE | ANGO |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | United Kingdom | United States |
| Employees | 2900 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.6M | 420.2M |
| IPO Year | N/A | 2004 |
| Metric | PSFE | ANGO |
|---|---|---|
| Price | $7.68 | $12.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.69 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 325.7K | 258.0K |
| Earning Date | 05-13-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $8.15 | $9.51 |
| Revenue Next Year | $6.25 | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $5.95 | $8.36 |
| 52 Week High | $15.02 | $13.99 |
| Indicator | PSFE | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 65.53 |
| Support Level | $6.53 | $10.45 |
| Resistance Level | $7.62 | $12.72 |
| Average True Range (ATR) | 0.56 | 0.41 |
| MACD | -0.12 | 0.09 |
| Stochastic Oscillator | 25.91 | 90.97 |
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.